Assessment of the Efficacy of a Cognitive-Behavioural Group Psychotherapy Programme for HIV-Infected Patients Referred to a Consultation-Liaison Psychiatry Department

Blanch, Jordi; Rousaud, Araceli; Hautzinger, Martin; Martínez, Estebán; Peri, Josep-Maria; Andrés, Susana Marqués; Cirera, E; Gatell, Josep-Maria; Gastó, Cristòbal

doi:10.1159/000049349

Cited by 22 publications

(6 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,6,63 The majority of studies investigating the efficacy of psychotherapy for people with depressive symptoms and HIV/AIDS have tested cognitive-behavioral treatment interventions, including cognitive restructuring, relaxation techniques, psychoeducation, and training in problem-solving, often in combination with psychopharmacological treatment. [64][65][66][67] Interpersonal therapy (IPT) has also been reviewed in several studies, which appear to provide evidence of its use for treating depressive symptoms as well. 68,69 Although research examining the efficacy of psychotherapy for people with HIV/AIDS is compelling, the vast majority of these studies set very liberal inclusion criteria with respect to depressive symptoms, including participants who did not meet criteria for depressive disorders, but exhibited some level of depressive symptoms.…”

Section: Discussionmentioning

confidence: 99%

Major Depression in Patients with HIV/AIDS and Substance Abuse

Berger-Greenstein

Cuevas

Brady

et al. 2007

AIDS Patient Care and STDs

View full text Add to dashboard Cite

Previous research has been inconsistent in documenting a strong relationship between depression and HIV/AIDS, although a recent meta-analysis of studies examining this issue indicates that rates of depression are modestly higher for this population. For the current study, conducted from 2001-2004, we sought to examine rates and types of depressive symptoms in a cohort of patients receiving HIV care at two urban medical centers. These patients were participants in an intervention study examining adherence and mental health in persons triply diagnosed with psychiatric disorders, substance use disorders, and HIV/AIDS. Nearly three quarters of these participants were people of color, two thirds described their sexual orientation as heterosexual, and the vast majority were unemployed. We sought to examine the relationship of depression to patients' adherence to antiretroviral medication regimens (highly active antiretroviral therapy [HAART]). Results obtained from structured clinical interviews and self-report questionnaires indicated that study participants experienced high rates of depressive symptoms, and that 72.9% of participants met criteria for major depressive disorder (MDD). The results of this study offer a detailed view of the incidence and nature of MDDs and depressive symptoms for an urban sample of substance-abusing adults with HIV/AIDS. Given the degree to which depressive symptoms and MDD appear to be prevalent for this group, as well as the observation that these symptoms are amenable to treatment, future research should focus on identifying helpful strategies and interventions for treating these symptoms, effective ways of providing linkages to care, and ways in which standardized assessment and treatment protocols might be adapted to better suit this population.

show abstract

Section: Discussionmentioning

confidence: 99%

Major Depression in Patients with HIV/AIDS and Substance Abuse

Berger-Greenstein

Cuevas

Brady

et al. 2007

AIDS Patient Care and STDs

View full text Add to dashboard Cite

show abstract

“…In fact, it emerges that the drug-dependent subjects express at the highest level the differences in NS, HA, and SD that have been found in the HIV population compared with the control group. This profile indicates the presence of a borderline or passive-aggressive personality profile [15, 16], according to the literature about drug-dependent subjects [1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28]. These personality traits, presumably related to the development of a drug dependence [28], may be relevant for the risk of HIV infection [29], for the difficult clinical management of drug-dependent HIV-positive subjects, and for the less consistent benefits from psychotherapy [12, 13, 14].…”

Section: Discussionmentioning

confidence: 99%

“…This information may be useful for the coordination of multimodal interventions for these patients [12, 13, 14]. …”

Section: Introductionmentioning

confidence: 99%

Personality Profile of HIV Outpatients: Preliminary Results and Remarks on Clinical Management

Fassino

Leombruni²,

Amianto³

et al. 2004

Psychother Psychosom

View full text Add to dashboard Cite

Background: Currently, HIV is one of the most widely spread epidemics in the world. The specificity of the mode of transmission, the well-known severity of the prognosis, and the kind of therapies used are peculiarities of this illness. Personality traits of individuals with HIV may influence conditions for the infection itself. On the other hand, it is possible that personality traits may influence the course of the illness and the willingness of the patients to adhere to treatment. The present study assessed the personality traits of a heterogeneous group of seropositive subjects compared with healthy controls to determine specific temperament and character traits of this population. Methods: The Temperament and Character Inventory (TCI) was administered to 126 HIV-positive outpatients belonging to different risk categories for HIV infection and to a sample of healthy individuals matched for sex, age, and socioeconomic parameters. Results: Drug-dependent HIV-positive patients displayed higher scores in novelty seeking and harm avoidance and lower scores in self-directedness compared with healthy controls. Non-drug-dependent HIV-positive subjects scored significantly higher in self-transcendence. Conclusions: Temperament and character features significantly differentiate the HIV-positive subjects from controls and those belonging to the different risk categories for HIV infection. Drug-dependent subjects with HIV display more impulsiveness, which possibly predates the HIV infection. They are also more fearful and lack self-directedness. Non-drug-dependent subjects express higher self-transcendence resources, possibly to overcome their difficulties. Both the temperament and character features may influence compliance with treatment and require specific interventions considering these subgroups.

show abstract

“…A few studies have reported significant reductions in depression, [171][172][173][174][175] improved immune control of latent HSV-2 virus, 174 and reduced urinary cortisol levels after CBSM. 174,175 The reduction in depression was directly related to reduction in cortisol levels in urine.…”

Section: Cognitive-behavioral Stress Managementmentioning

confidence: 99%

Prevalence, impact, and management of depression and anxiety in patients with HIV: a review

Bakhla¹,

Saini²

2016

NBHIV

View full text Add to dashboard Cite

The prevalence of depression and anxiety in people living with HIV/AIDS (PLWHA) ranges from 7.2% to 71.9% and 4.5% to 82.3%, respectively. This wide variation is attributed to differences in sample size and characteristics, and methodology for assessment of anxiety and depression. Moreover, anxiety and depression increase the morbidity of HIV by poor adherence to treatment and various other significant mechanisms. Early identification and effective management of these disorders is associated with improved antiretroviral adherence and improved quality of life in PLWHA. Different treatment modalities, including pharmacological and nonpharmacological therapies, are used for the management of anxiety and depression in PLWHA. Benzodiazepines are indicated for short periods of time. Clonazepam and lorazepam are safe in terms of drug-drug interactions and may be preferred. Selective serotonin reuptake inhibitors are safer than tricyclic antidepressants. Though the different selective serotonin reuptake inhibitors are supposed to be equally effective, to avoid interactions with antiretrovirals, the better options are sertraline, citalopram, and escitalopram. Various nonpharmacological therapies, including cognitive behavior therapy, interpersonal therapy, supportive psychotherapy, cognitive-behavioral-oriented group psychotherapy, experiential group psychotherapy, cognitive-behavioral stress management, stress management interventions, cognitive remediation therapy, mindfulness-based therapy, and aerobic and resistance exercise have been reported to be useful in treating depression among PLWHA. However, definitive evidence to decide which nonpharmacological intervention is most beneficial for the management of anxiety and depression in PLWHA is still required.

show abstract

Assessment of the Efficacy of a Cognitive-Behavioural Group Psychotherapy Programme for HIV-Infected Patients Referred to a Consultation-Liaison Psychiatry Department

Cited by 22 publications

References 21 publications

Major Depression in Patients with HIV/AIDS and Substance Abuse

Major Depression in Patients with HIV/AIDS and Substance Abuse

Personality Profile of HIV Outpatients: Preliminary Results and Remarks on Clinical Management

Prevalence, impact, and management of depression and anxiety in patients with HIV: a review

Contact Info

Product

Resources

About